Allworth Financial’s Collegium Pharmaceutical COLL Stock Holding History

Allworth Financial’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$175K	Buy	4,826 +418	+9%	+$14.3K	﹤0.01%	1569
2026 Q1	$146K	Buy	4,408 +38	+0.9%	+$1.61K	﹤0.01%	1595
2025 Q4	$202K	Buy	4,370 +15	+0.3%	+$628	﹤0.01%	1335
2025 Q3	$152K	Buy	4,355 +4	+0.1%	+$139	﹤0.01%	1446
2025 Q2	$129K	Buy	4,351 +4,293	+7,402%	+$122K	﹤0.01%	1404
2025 Q1	$1.55K	Buy	58 +7	+14%	+$214	﹤0.01%	3305
2024 Q4	$1.66K	Hold	51	–	–	﹤0.01%	3217
2024 Q3	$1.97K	Hold	51	–	–	﹤0.01%	2975
2024 Q2	$1.65K	Hold	51	–	–	﹤0.01%	3001
2024 Q1	$1.98K	Hold	51	–	–	﹤0.01%	2814
2023 Q4	$1.57K	Sell	51 -5	-9%	-$125	﹤0.01%	2779
2023 Q3	$1.25K	Buy	56 +5	+10%	+$114	﹤0.01%	2755
2023 Q2	$1.1K	Hold	51	–	–	﹤0.01%	2701
2023 Q1	$1.22K	Hold	51	–	–	﹤0.01%	2600
2022 Q4	$1.18K	Buy	51 +39	+325%	+$786	﹤0.01%	2417
2022 Q3	$0	Buy	+12	New	+$212	﹤0.01%	2722

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Allworth Financial's COLL Position: Q2 2026 in Review

Allworth Financial increased its Collegium Pharmaceutical (COLL) stake by 9.5% in Q2 2026, buying an estimated $14.3K and bringing the position to 4,826 shares worth $175K. The position accounts for ﹤0.01% of the portfolio, ranked #1569.

Allworth Financial first reported a position in COLL in Q3 2022 and has held it in 16 quarters since. The position peaked at $202K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Allworth Financial held 4,826 shares of Collegium Pharmaceutical worth $175K as of Q2 2026.
Allworth Financial bought 418 Collegium Pharmaceutical shares in Q2 2026, an estimated $14.3K.
Collegium Pharmaceutical made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #1569 holding.
Allworth Financial first reported a position in Collegium Pharmaceutical in Q3 2022 and has held it in 16 quarters since.
Allworth Financial's Collegium Pharmaceutical position peaked at $202K in Q4 2025.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.